The global atelocollagen market is entering an intensive phase of technology-driven scaling, with industrial revenues progressing steadily on a multi-billion dollar trajectory over the decade.  Global biotechnology labs, regenerative medicine developers, and premium aesthetic pharmacology hubs are aggressively scaling procurement of ultra-pure biomaterials as clinical safety mandates...